Inhibition of C-C chemokine receptor-2 improves insulin resistance and hepatic steatosis in db/db mice

被引：0
|
作者：
Tamura, Yukinori
Sugimoto, Masayuki
Murayama, Toshinori
Kita, Toru
Yokode, Masayuki
Araikyoto, Hidenori
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [1] C-C chemokine receptor-2 inhibitor ameliorates insulin resistance and hepatic steatosis in db/db mice.
    Tamura, Yukinori
    Arai, Hidenon
    Sugimoto, Masayuki
    Murayama, Toshinori
    Ueda, Yukihiko
    Kanamori, Hiroshi
    Ono, Koh
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    [J]. CIRCULATION, 2007, 116 (16) : 170 - 170
  • [2] α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2
    Kim, Hong Min
    Kim, You Mi
    Huh, Ji Hye
    Lee, Eun Soo
    Kwon, Mi Hye
    Lee, Bo Ra
    Ko, Hyun-Jeong
    Chung, Choon Hee
    [J]. PLOS ONE, 2017, 12 (06):
  • [3] C-C Chemokine Receptor 2 Inhibitor Improves Diet-Induced Development of Insulin Resistance and Hepatic Steatosis in Mice
    Tamura, Yukinori
    Sugimoto, Masayuki
    Murayama, Toshinori
    Minami, Manabu
    Nishikaze, Yuki
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (03) : 219 - 228
  • [4] Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
    Tamura, Yukinori
    Sugimoto, Masayuki
    Murayama, Toshinori
    Ueda, Yukihiko
    Kanamori, Hiroshi
    Ono, Koh
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (12) : 2195 - 2201
  • [5] Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice
    Kim, Young-Je
    Jung, Un Ju
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [6] C-c Chemokine Receptor 2 Inhibitor Ameliorates Diet-induced Insulin Resistance and Hepatic Steatosis in Mice
    Tamura, Yukinori
    Murayama, Toshinori
    Minami, Manabu
    Nishikaze, Yuki
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    [J]. CIRCULATION, 2009, 120 (18) : S1051 - S1051
  • [7] Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice
    Omori, Kazuno
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Nomoto, Hiroshi
    Kameda, Hiraku
    Cho, Kyuyong
    Terauchi, Yasuo
    Atsumi, Tatsuya
    [J]. DIABETES, 2019, 68
  • [8] PHARCOLOGICAL BLOCKADE OF CCR2 INHIBITS THE DEVELOPMENT OF INSULIN RESISTANCE AND HEPATIC STEATOSIS IN DB/DB MICE
    Tamura, Y.
    Sugimoto, M.
    Murayama, T.
    Kita, T.
    Yokode, M.
    Arai, H.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 12 - 13
  • [9] Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
    Zhai, Mingming
    Yan, Xi
    Liu, Jiangzheng
    Long, Zi
    Zhao, Siyan
    Li, Wendan
    Liu, Ying
    Hai, Chunxu
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1035 - 1042
  • [10] Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy
    Yang, S. J.
    IglayReger, H. B.
    Kadouh, H. C.
    Bodary, P. F.
    [J]. DIABETOLOGIA, 2009, 52 (05) : 972 - 981
12345